国科恒泰：8月27日召开董事会会议

Group 1 - The company Guoke Hengtai (SZ 301370) announced the convening of its 43rd board meeting on August 27, 2025, to review the semi-annual report for 2025 [1] - For the first half of 2025, the revenue composition of Guoke Hengtai was as follows: vascular interventional treatment materials accounted for 71.09%, other products 14.58%, non-vascular interventional treatment materials 5.27%, orthopedic implant materials 5.12%, and oral products 2.25% [1]